4117 |
In-Depth Technical Aspect of LM PCI |
Sunao Nakamura |
Apr. 25. 17 |
4116 |
Impact of Complete Revascularization for MVD PCI |
Seung-Jung Park |
Apr. 25. 17 |
4115 |
Generalizability of EXCEL and NOBLE; Comparison with IRIS-MAIN Registry |
Duk-Woo Park |
Apr. 25. 17 |
4114 |
Pre and Post EXCEL and NOBLE Era; What Will Change in LM Treatment? |
Tullio Palmerini |
Apr. 25. 17 |
4113 |
PCI vs. CABG for Left Main or Multivessel CAD: Evolution and Current Status |
Cheol Whan Lee |
Apr. 25. 17 |
4112 |
My Practice with LUTONIX DCB |
Yun-Hyeong Cho |
Apr. 25. 17 |
4111 |
Newer CABG Trials: Insights from ART and CORONARY |
David Paul Taggart |
Apr. 25. 17 |
4110 |
My Practice with LUTONIX DCB |
Jong-Young Lee |
Apr. 25. 17 |
4109 |
How to Maximize DCB Outcome |
Seung-Woon Rha |
Apr. 25. 17 |
4108 |
Indonesia Responds: How Would I Treat the Case in Indonesia |
Teguh Santoso |
Apr. 25. 17 |